Romiplostim
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia